A nationwide recall has been issued for ReBoost nasal spray due to microbial contamination, prompting concerns for consumers and increased scrutiny of over-the-counter drug safety. The homeopathic spray, sold at major retailers like CVS, Walmart, and Amazon, is being voluntarily recalled by manufacturer MediNatura New Mexico following intervention from the Food and drug Administration. The FDA has stated the product tested positive for potentially harmful bacteria and mold, and is advising consumers to immediately discontinue use and return the product for a full refund.
A widely distributed nasal spray sold nationwide is being recalled due to the detection of mold and microbial contamination, posing a potential health risk to consumers.
MediNatura New Mexico announced a voluntary recall of its ReBoost nasal spray, a homeopathic product available at major retailers including CVS, Walmart, and Amazon, used to relieve symptoms of nasal congestion, headache, sinus pressure, and other common respiratory issues. The action follows intervention by the Food and Drug Administration (FDA), which issued an alert regarding risks associated with the product’s use.
The recall centers on a specific lot of ReBoost nasal spray, identified as lot number 224268 with an expiration date of December 2027, which the FDA says tested positive for dangerous levels of bacterial contamination, including species of Achromobacter, as well as yeast and mold. This contamination presents a health risk, particularly for individuals with compromised immune systems.
The FDA’s action underscores heightened scrutiny of over-the-counter drug manufacturing and quality control. The agency warns that use of the contaminated spray carries a “reasonable probability” of serious adverse effects in those with weakened immune systems, such as cancer patients, individuals undergoing immunosuppressive therapy, or people with autoimmune diseases. The presence of mold and bacteria in the spray could trigger respiratory infections, potentially endangering vulnerable users.
While no adverse events have been reported to date in connection with the recall, both the FDA and MediNatura are urging consumers to immediately discontinue use to avoid potential health risks.
The affected ReBoost nasal spray is packaged in 20 ml bottles and is identifiable by its label. Consumers who have purchased the product should stop using it immediately and return it to the point of purchase for a full refund, according to the FDA.
MediNatura emphasized in a statement to NBC Chicago that, despite being on the market for over two years without reported incidents, the company is conducting the voluntary recall “out of an abundance of caution” to protect consumer health. This proactive approach is becoming increasingly common as companies prioritize safety and transparency.
Consumers possessing the recalled lot should follow the return instructions. The FDA recommends prompt return of any affected product to prevent continued use. MediNatura has stated it will continue to work closely with health authorities to resolve the issue and ensure the safety of its products going forward.
